Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Tax Provisions (2016 - 2025)

Cumberland Pharmaceuticals' Tax Provisions history spans 16 years, with the latest figure at $22989.0 for Q4 2025.

  • For Q4 2025, Tax Provisions rose 142.32% year-over-year to $22989.0; the TTM value through Dec 2025 reached $40000.0, up 263.23%, while the annual FY2025 figure was $40000.0, 300.0% up from the prior year.
  • Tax Provisions for Q4 2025 was $22989.0 at Cumberland Pharmaceuticals, up from $5670.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $48150.0 in Q4 2022 and bottomed at -$54327.0 in Q4 2024.
  • The 5-year median for Tax Provisions is $6938.0 (2023), against an average of $7395.1.
  • The largest annual shift saw Tax Provisions crashed 78.22% in 2021 before it skyrocketed 284.71% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $12516.0 in 2021, then surged by 284.71% to $48150.0 in 2022, then crashed by 85.59% to $6938.0 in 2023, then crashed by 883.04% to -$54327.0 in 2024, then skyrocketed by 142.32% to $22989.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Tax Provisions are $22989.0 (Q4 2025), $5670.0 (Q3 2025), and $5671.0 (Q2 2025).